Conferences
Photographs from the Fourth John Vane Memorial Symposium (2009) on Prostacyclin Science & Pulmonary Vascular Disease
Chris Thiemermann (CEO, WHRL), Martine Rothblatt (CEO, United Therapeutics), Rod Flower FRS (WHRI), Sheila Haworth CBE (University College London), Marc Humbert (Université Paris-Sud)
Larry H Somerville (Senior Vice President, Lung Rx), Chandan Alam & Brendan Whittle (William Harvey Research Institute)
Delegates of the Fourth John Vane Memorial Symposium
Question & Answer at the Fourth John Vane Memorial Symposium on Prostacyclin & Pulmonary Vascular Disease
Bina Aspen, Lady Daphne Vane, Cheryl Measures (WHRI), Martine Rothblatt (CEO, United Therapeutics)
Mark Caulfield (Director, William Harvey Research Institute), Chris Thiemermann (WHRI & CEO, William Harvey Research Limited)
Gustav Born (WHRI) and Brendan Whittle (WHRI & Director, WHRL)
Debate Panel: Should Combination Therapy be the Goal?
Debate Panel: Simon Gibbs (Imperial College), Nick Ross, Debate Moderator
Debate Moderator: Nick Ross
Debate Panel: Robert Bourge (University of Alabama), Nick Ross, Debate Moderator, Marc Humbert (Université Paris-Sud), Robert Naeije (Erasme University Hospital), Simon Gibbs (Imperial College)
Chris Thiemermann (WHRI & CEO, WHRL), Jane Mitchell (Imperial College), Cheryl Measures (WHRI), Rod Flower FRS (WHRI & Director, WHRL)
Delegates of the Fourth John Vane Memorial Symposium with Martine Rothblatt (CEO, United Therapeutics), Bina Aspen, & far right, Robert Grover (United Therapeutics)
Andrew Peacock (Scottish Pulmonary Vascular Unit) with Brendan Whittle (WHRI)
Lady Daphne Vane
Chris Thiemermann (CEO, William Harvey Research Limited) and Martine Rothblatt (CEO, United Therapeutics)
Question & Answer: Delegates at the John Vane Memorial Symposium
Paola Argiento, Roberto Badagliacca, Michel D'Alto, Roberto Poscia, Dario Vizza, Stefano Ghio (Dompe) with Robert Grover (United Therapeutics)
Lady Daphne Vane with Martine Rothblatt (CEO, United Therapeutics)
Mauro Perretti (WHRI & Director, WHRL), Gustav Born (WHRI) and Chris Thiemermann (CEO, WHRL)
Ray Pediani and Thanh Thao Duong (United Therapeutics) with Nick Ross
Lewis Rubin (University of California), Martine Rothblatt (CEO, United Therapeutics), Robert Bourge (University of Alabama)
Ray Pediani (United Therapeutics) & Jim White (University of Rochester Medical Center)
Martine Rothblatt (CEO, United Therapeutics) and Robert Bourge (University of Alabama)
Ray Pediani and Lady Daphne Vane
Thanh Thao Duong (United Therapeutics) and Yochai Adir (Carmel Medical Center)
Martine Rothblatt (CEO, United Therapeutics) and Ray Pediani (Director, European Medical Affairs, United Therapeutics)
Institute of Directors
Jane Phillips (United Therapeutics), Cheryl Measures (William Harvey Research Institute)
Sarah Thinnesen (United Therapeutics), Robert Bourge, Thanh Thao Duong, Amadeus Flemming, Jane Philips & Ray Pediani
|
